CoChat

Targeting of intracellular oncoproteins with peptide-centric CARs

Open access
Yarmarkovich, Mark, Marshall, Quinlen F., Warrington, John M., Premaratne, Rasika, Farrel, Alvin, Groff, David, Li, Wei, di Marco, Moreno, Runbeck, Erin, Truong, Hau, Toor, Jugmohit S., Tripathi, Sarvind, Nguyen, Son, Shen, Helena, Noel, Tiffany, Church, Nicole L., Weiner, Amber, Kendsersky, Nathan, Martinez, Dan, Weisberg, Rebecca, Christie, Molly, Eisenlohr, Laurence, Bosse, Kristopher R., Dimitrov, Dimiter S., Stevanovic, Stefan, Sgourakis, Nikolaos G., Kiefel, Ben R., Maris, John M. · 2023 · Nature
Cited by 82

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

The majority of oncogenic drivers are intracellular proteins, constraining their immunotherapeutic targeting to mutated peptides (neoantigens) presented by individual human leukocyte antigen (HLA) allotypes 1. However, most cancers have a modest mutational burden that is insufficient for generating responses using neoantigen-based therapies 2,3. Neuroblastoma is a paediatric cancer that harbours few mutations and is instead driven by epigenetically deregulated transcriptional networks 4. Here we show that the neuroblastoma immunopeptidome is enriched with peptides derived from proteins essential for tumorigenesis. We focused on targeting the unmutated peptide QYNPIRTTF discovered on HLA-A*24:02, which is derived from the neuroblastoma-dependency gene and master transcriptional regulator PHOX2B. To target QYNPIRTTF, we developed peptide-centric chimeric antigen receptors (PC-CARs) through a counter panning strategy using predicted potentially cross-reactive peptides. We further proposed that PC-CARs can recognize peptides on additional HLA allotypes when presenting a similar overall molecular surface. Informed by our computational modelling results, we show that PHOX2B PC-CARs also recognize QYNPIRTTF presented by HLA-A*23:01, the most common non-A2 allele in people with African ancestry. Finally, we demonstrate potent and specific killing of neuroblastoma cells expressing these HLAs in vitro and complete tumour regression in mice. These data suggest that PC-CARs have the potential to expand the pool of immunotherapeutic targets to include non-immunogenic intracellular oncoproteins and allow targeting through additional HLA allotypes in a clinical setting.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41586-023-06706-0

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 82

Metadata

Authors
Yarmarkovich, M., Marshall, Q. F., Warrington, J. M., Premaratne, R., Farrel, A., Groff, D., Li, W., di Marco, M., Runbeck, E., Truong, H., Toor, J. S., Tripathi, S., Nguyen, S., Shen, H., Noel, T., Church, N. L., Weiner, A., Kendsersky, N., Martinez, D., Weisberg, R., Christie, M., Eisenlohr, L., Bosse, K. R., Dimitrov, D. S., Stevanovic, S., Sgourakis, N. G., Kiefel, B. R., & Maris, J. M.
Venue
Nature
Published
2023-11-08
Volume
623
Issue
7988
Pages
820-827
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W4388488706
Cited by
82
References
10
FWCI
8.49
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Targeting of intracellular oncoproteins with peptide-centric CARs. https://app.cochat.ai/papers/10.1038/s41586-023-06706-0
The paper
Yarmarkovich, M., Marshall, Q. F., Warrington, J. M., Premaratne, R., Farrel, A., Groff, D., Li, W., di Marco, M., Runbeck, E., Truong, H., Toor, J. S., Tripathi, S., Nguyen, S., Shen, H., Noel, T., Church, N. L., Weiner, A., Kendsersky, N., Martinez, D., . . . Maris, J. M. (2023). Targeting of intracellular oncoproteins with peptide-centric CARs. Nature. https://doi.org/10.1038/s41586-023-06706-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.